The Five-Factor Score Revisited

Bligny, 2004, Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients., Arthritis Rheum, 51, 83, 10.1002/art.20082

Charlier, 2009, Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients., Ann Rheum Dis, 68, 658, 10.1136/ard.2008.088302

Cohen, 2007, Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients., Arthritis Rheum, 57, 686, 10.1002/art.22679

Cox, 1972, Regression models and life tables., J R Stat Soc, 34, 187

de Groot, 2001, Development and validation of a disease extent index for Wegener's granulomatosis., Clin Nephrol, 55, 31

de Groot, 2009, Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial., Ann Intern Med, 150, 670, 10.7326/0003-4819-150-10-200905190-00004

Exley, 1996, Clinical disease activity in systemic vasculitis., Curr Opin Rheumatol, 8, 12, 10.1097/00002281-199601000-00002

Gayraud, 2001, Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients., Arthritis Rheum, 44, 666, 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A

Guillevin, 2003, Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients., Arthritis Rheum, 49, 93, 10.1002/art.10922

Guillevin, 1997, A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis., Arthritis Rheum, 40, 2187, 10.1002/art.1780401213

Guillevin, 1996, Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients., Medicine (Baltimore), 75, 17, 10.1097/00005792-199601000-00003

Guillevin, 2005, Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients., Medicine (Baltimore), 84, 313, 10.1097/01.md.0000180792.80212.5e

Haworth, 1985, Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis., Br Med J (Clin Res Ed), 290, 1775, 10.1136/bmj.290.6484.1775

Hogan, 1996, Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis., J Am Soc Nephrol, 7, 23, 10.1681/ASN.V7123

Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies., N Engl J Med, 349, 36, 10.1056/NEJMoa020286

Jayne, 2007, Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis., J Am Soc Nephrol, 18, 2180, 10.1681/ASN.2007010090

Jennette, 1994, Nomenclature of systemic vasculitides. Proposal of an international consensus conference., Arthritis Rheum, 37, 187, 10.1002/art.1780370206

Jennings, 1997, Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis., Am J Respir Crit Care Med, 155, 1101, 10.1164/ajrccm.155.3.9116994

Kaplan, 1958, Nonparametric estimation from incomplete observations., J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

Khan, 2007, Outcome of patients with small-vessel vasculitis admitted to a medical ICU., Chest, 131, 972, 10.1378/chest.06-2464

Klemmer, 2003, Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis., Am J Kidney Dis, 42, 1149, 10.1053/j.ajkd.2003.08.015

Lamprecht, 2003, Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis., Arthritis Res Ther, 5, R25, 10.1186/ar610

Lauque, 2000, Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P)., Medicine (Baltimore), 79, 222, 10.1097/00005792-200007000-00003

Leavitt, 1990, The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis., Arthritis Rheum, 33, 1101, 10.1002/art.1780330807

Lightfoot, 1990, The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa., Arthritis Rheum, 33, 1088, 10.1002/art.1780330805

Luqmani, 1994, Classical versus non-renal Wegener's granulomatosis., Q J Med, 87, 161

Luqmani, 1994, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis., QJM, 87, 671

Mahr, 2001, Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up., Rheumatology (Oxford), 40, 492, 10.1093/rheumatology/40.5.492

Masi, 1990, The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)., Arthritis Rheum, 33, 1094, 10.1002/art.1780330806

Merkel, 2005, Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7., J Rheumatol, 32, 2488

Mouthon, 2002, Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years., Medicine (Baltimore), 81, 27, 10.1097/00005792-200201000-00002

Mukhtyar, 2008, Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force., Ann Rheum Dis, 67, 1004, 10.1136/ard.2007.071936

Pagnoux, 2008, Azathioprine or methotrexate maintenance for ANCA-associated vasculitis., N Engl J Med, 359, 2790, 10.1056/NEJMoa0802311

Ribi, 2010, Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients., Arthritis Rheum, 62, 1186, 10.1002/art.27340

Ribi, 2008, Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients., Arthritis Rheum, 58, 586, 10.1002/art.23198

Stone, 2001, A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)., Arthritis Rheum, 44, 912, 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5